BCL2 and acute myeloid leukemia: Venetoclax (a BH3 mimetic), a Bcl‐2 antagonist used to trigger apoptosis in cancers, inhibits proliferation and colony formation in AML [109], and in combination with venetoclax induces strong apoptosis in both AML and MM.